Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Expects STD Claims Enforcement To Deter Future Violations

This article was originally published in The Tan Sheet

Executive Summary

FDA will consider prosecuting executives of firms making unapproved sexually transmitted disease treatment claims for OTC drugs and nutritional products, the targets of its latest enforcement sweep.
Advertisement

Related Content

DoJ Casts Criminal Charge Net For Supplements Making STD Claims
Criminal Charges Against Hoodia Suppliers, Consent Decree For Herpes Claim Firm
Tracking Federal Agencies’ Enforcement In Supplement Space
Spiked “Supplements” For Diabetes, Pain On The Rise
Spiked “Supplements” For Diabetes, Pain On The Rise
FDA Regulation Of Homeopathics Does Not Pre-empt Damages Claims – Court
FDA Regulation Of Homeopathics Does Not Pre-empt Damages Claims – Court
Supplement Marketer Faces Prison For Misbranding And Tax Fraud
FDA Targets Executives With Powerful Misdemeanor Strategy
FDA Targets Executives With Powerful Misdemeanor Strategy
Advertisement
UsernamePublicRestriction

Register

PS105030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel